Foley & Lardner LLP congratulates K Health, an AI primary care platform that aims to reinvent primary care by providing patients remote access to health care services through their smartphones, on its $50 million equity funding round led by Claure Group, with additional support from Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.
K Health has developed a chat function that uses artificial intelligence to suggest potential diagnoses for consumers who enter symptoms and also takes into account the user’s medical history, age, and gender. The company also built out an AI “copilot” that interacts with patients, collects information, integrates with electronic medical records, and assembles insights to improve doctors’ clinical decision-making.
Partner Thomas (T.J.) Ferrante, a member of Foley’s national Telemedicine & Digital Health Industry Team, advised K Health on regulatory issues.
Foley’s Telemedicine & Digital Health Industry Team helps venture-backed and high-growth companies embrace emerging issues in virtual care, enabling them to provide innovative care for patients in new markets around the block and around the world. Foley is committed to helping entrepreneurs fulfill their goals of harnessing new technology to reach patients anywhere, delivering care without borders or geographic limitations. The firm helps create fully-fledged telemedicine offerings, providing end-to-end legal services by coupling precise strategic guidance with rapid turnarounds to maintain that sense of urgency necessary to launch new initiatives and remain competitive in the marketplace.
Learn more at www.foley.com/telemedicine.
